menu
    • menu

    Company profile for Enliven Therapeutics

    NEW Drugs in Dev: 2
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Enliven Therapeutics is a biopharmaceutical company focused on the discovery and development of small molecule inhibitors to help patients with cancer live not only longer, but better. Enliven aims to address existing and emerging unmet needs with a precision oncology approach that improves survival and enhances overall patient well-being. Enliven’s discovery process combines deep insights from clinically validated biologica...
    Enliven Therapeutics is a biopharmaceutical company focused on the discovery and development of small molecule inhibitors to help patients with cancer live not only longer, but better. Enliven aims to address existing and emerging unmet needs with a precision oncology approach that improves survival and enhances overall patient well-being. Enliven’s discovery process combines deep insights from clinically validated biological targets and differentiated chemistry to design potentially first-in-class or best-in-class therapies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Enliven TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    6200 Lookout Road Boulder, CO 80301
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.enliventherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/enliventherapeutics/about/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enliven Therapeutics Reveals 2025 Financials And Business Update
    Enliven Therapeutics Reveals 2025 Financials And Business Update

    04 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/enliven-therapeutics-reports-fourth-quarter-and-full-year-2025-financial-results-and-provides-a-business-update-302702806.html

    PR NEWSWIRE
    04 Mar 2026
    Share Share
    Enliven Therapeutics at TD Cowen's 46th Health Care Conference
    Enliven Therapeutics at TD Cowen's 46th Health Care Conference

    25 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/enliven-therapeutics-to-present-at-the-td-cowen-46th-annual-health-care-conference-302697474.html

    PR NEWSWIRE
    25 Feb 2026
    Share Share
    Enliven Sets 2026 Milestones on ELVN-001 CML Data
    Enliven Sets 2026 Milestones on ELVN-001 CML Data

    08 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/enliven-reports-positive-initial-phase-1b-data-for-elvn-001-in-cml-and-outlines-2026-clinical-milestones-302655863.html

    PR NEWSWIRE
    08 Jan 2026
    Share Share
    Enliven Therapeutics Strengthens Board For Next Development Phase
    Enliven Therapeutics Strengthens Board For Next Development Phase

    07 Jan 2026

    // PR NEWSWIRE BIO

    https://www.prnewswire.com/news-releases/enliven-therapeutics-bolsters-board-to-prepare-for-next-phase-of-development-302654440.html

    PR NEWSWIRE BIO
    07 Jan 2026
    Share Share
    Enliven Announces New CEO to Drive Next Phase of Development
    Enliven Announces New CEO to Drive Next Phase of Development

    11 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/enliven-therapeutics-announces-new-ceo-to-drive-next-phase-of-development-302638603.html

    PR NEWSWIRE
    11 Dec 2025
    Share Share
    Enliven Therapeutics Discloses Nasdaq LR-Permitted Inducement
    Enliven Therapeutics Discloses Nasdaq LR-Permitted Inducement

    11 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/enliven-therapeutics-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-302639654.html

    PR NEWSWIRE
    11 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search